AIM ImmunoTech Shares Are Trading Higher After the Company Announced the Print Publication of the Data Analysis From Its Early Access Program Studying Ampligen.
AIM ImmunoTech Shares Are Trading Higher After the Company Announced the Print Publication of the Data Analysis From Its Early Access Program Studying Ampligen.
aim immunotech股票价格上涨，该公司宣布早期接触项目研究ampelgen的数据分析报告已印刷出版。
AIM ImmunoTech Shares Are Trading Higher After the Company Announced the Print Publication of the Data Analysis From Its Early Access Program Studying Ampligen.
aim immunotech股票价格上涨，该公司宣布早期接触项目研究ampelgen的数据分析报告已印刷出版。